515MO Encorafenib + Cetuximab (EC) + FOLFIRI for BRAF V600E-mutant Metastatic Colorectal Cancer (mcrc): Updated Results from the BREAKWATER Safety Lead-in (SLI)
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined